Abstracts Archive - Page 31 of 1683 - ATC Abstracts

2022 American Transplant Congress
Does the New Kidney Transplant Allocation System Impact Delayed Graft Function Rates After Kidney Transplantation?
P. N. Chotai¹, F. Siddiqui², A. Logan³, K. Washburn⁴, A. Schenk⁵, A. Limkemann³
¹Division of Transplantation, Department of General Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, ²Ohio State University, Bloomfield, NJ, ³The Ohio State University Wexner Medical Center, Columbus, OH, ⁴The Ohio State University, Columbus, OH, ⁵Ohio State University Wexner Medical Center, Bexley, OH
*Purpose: The Organ Procurement and Transplantation Network (OPTN) implemented a new, distance based, kidney transplant allocation system (nKAS) for recipients of deceased donor kidney transplant…
2022 American Transplant Congress
Early Post-Operative Thrombotic Microangiopathy in Deceased Donor Kidney Transplant: A Retrospective Case Series
R. Seneriz¹, A. Mattiazzi¹, G. Guerra¹, T. Harrington², M. Velasquez³
¹Miami Transplant Institute, Miami, FL, ²University of Miami, Miami, FL, ³Jackson Memorial Hospital, Miami, FL
*Purpose: Transplant associated thrombotic microangiopathy (TA-TMA) is characterized by endothelial injury along with thrombocytopenia, microangiopathic hemolytic anemia (MAHA) and kidney graft dysfunction. It can be…
2022 American Transplant Congress
Retransplantation in a High-Volume Institution: Historical, Socioeconomic and Survival Trends
D. von Ahrens, O. Sulimani, M. Holzner, M. Akhtar, S. Florman, A. Arvelakis
The Mount Sinai Hospital, New York, NY
*Purpose: Retransplantation for liver allograft failure is a challenge within the field. The evolution of organ allocation policy from Child to MELD in 2002 and…
2022 American Transplant Congress
Pump Resistance Thresholds and Graft Outcomes in Machine Perfused Kidneys-A Single Center Retrospective Study
S. Sivan, J. Gaynor, M. Tabbara, G. Ciancio
Univ of Miami Miller School of Medicine, Miami, FL
*Purpose: Perfusion parameters are increasingly used to assess the quality of organs and to make decisions about discarding the organ. Resistive index(RI) has been an…
2022 American Transplant Congress
Presence of AT1R Antibody Pre-Transplant Does Not Correlate with Rejection in a Large Pediatric Kidney Transplant Cohort
K. Hitchman¹, P. K. Shah¹, D. Fritze¹, R. Hinojosa², D. Ranch¹
¹University Health Transplant Institute, San Antonio, TX, ²Pharmacy, University Health Transplant Institute, San Antonio, TX
*Purpose: Describe correlations between pre-transplant (PreTXP) presence of anti-angiotensin II receptor type 1 antibodies (AT1RAb) and post-transplant (PostTXP) outcomes in a pediatric kidney transplant (PKT)…
2022 American Transplant Congress
Ultrasound Assessing Donor Kidney Quality in Deceased Donor Kidney Transplantation
S. Yun¹, K. Lee¹, S. Park², J. Park¹
¹Surgery, Samsung Medical Center, Seoul, Korea, Republic of, ²Radiology and Center for Imaging Science, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: We evaluated the role of functional kidney volume using donor kidney ultrasound (US) alone or in combination with other donor factors and parameters appropriate…
2022 American Transplant Congress
DCD Liver Grafts Can Safely be Used for Recipients with Grade 1-2 Portal Vein Thrombosis
L. A. Mercado¹, H. K. Bhangu¹, K. R. Musto², K. D. Watt³, B. Taner⁴, C. B. Rosen⁵, T. Taner⁵, L. Yang¹, D. M. Harnois¹, J. D. LeGout⁶, K. P. Croome⁴
¹Liver Transplant, Mayo Clinic, Jacksonville, FL, ²Transplant, Mayo Clinic, Jacksonville, FL, ³Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, ⁴Transplant Surgery, Mayo Clinic, Jacksonville, FL, ⁵Transplant Surgery, Mayo Clinic, Rochester, MN, ⁶Radiology, Mayo Clinic, Jacksonville, FL
*Purpose: Limited data is available in the literature regarding patients with portal vein thrombosis (PVT) receiving a liver transplant (LT) from a donation after circulatory…
2022 American Transplant Congress
National Attitudes Towards Early Liver Transplantation for Alcoholic Liver Disease
J. Mitchell¹, K. Nijhar¹, K. Herrick-Reynolds², H. Sung¹, P. Chen¹, D. L. Segev¹, E. King¹, A. Cameron¹
¹Department Of Surgery, Johns Hopkins University, Baltimore, MD, ²Department Of Surgery, Walter Reed National Military Medical Center, Bethesda, MD
*Purpose: Pre-transplant abstinence requirements, notably the 6-month sobriety guideline, limit access to liver transplant for patients with severe alcoholic hepatitis (SAH). This study examines the…
2022 American Transplant Congress
Single Center Experience Transplanting Deceased Donor Kidneys with Poor Pump Parameters
M. Garner, B. Sharda, A. Farney, G. Orlando, C. Jay, J. Rogers, A. Reeves-Daniel, A. Mena-Gutierrez, N. Sakhovskaya, R. Stratta
Transplant Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: With the growth of marginal deceased donor (DD) kidney utilization, machine preservation or “pumping” of selected kidneys has become an increasingly important part of…
2022 American Transplant Congress
Outcomes of Kidney Transplant Recipients with Covid-19 in Singapore Treated with Sotrovimab in the Era of the Delta Variant
M. R. D'Costa¹, H. K. Sran¹, E. Wong¹, Z. Chang², Y. Chua², J. Somani³, L. Lum³, A. Vathsala¹
¹National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore, ²Medicine, National University Hospital, Singapore, Singapore, ³Infectious Diseases, National University Hospital, Singapore, Singapore
*Purpose: Kidney transplant recipients (KTRs) are at higher risk for severe COVID-19 caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Sotrovimab decreases the risk…